![Pei Ling Tsai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pei Ling Tsai
Corporate Officer/Principal chez CytoPharm, Inc.
Profil
Pei Ling Tsai is currently working as a Commission-Clinical Studies at CytoPharm, Inc. She completed her undergraduate degree from National Yang Ming University.
Postes actifs de Pei Ling Tsai
Sociétés | Poste | Début |
---|---|---|
CytoPharm, Inc.
![]() CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | 22/09/2011 |
Formation de Pei Ling Tsai
National Yang Ming University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
CytoPharm, Inc.
![]() CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |